Table 3.

Correlations (Pearson's r) between pre-therapy PPI levels and symptom improvement at follow-up.

PANSS symptom improvement	CBTp + TAU group (n = 23; 16 men and 7 women)				TAU-alone group (n = 17, 14 men and 3 women)
	Mean PPI (across 30-, 60-, 120 ms)	30-ms PPI	60-ms PPI	120-ms PPI	Mean PPI (across 30-, 60-, 120 ms)	30-ms PPI	60-ms PPI	120-ms PPI
Absolute change
Positive symptoms	0.316 (M: 0.450; W: 0.141)	0.189	0.270	0.320 (M: 0.325; W: 0.297)	− 0.084	− 0.120	− 0.111	− 0.007
Negative symptoms	0.407⁎ (M: 0.283; W: 0.774⁎)	0.126	0.191	0.665⁎⁎⁎ (M: 0.477#; W: 0.895⁎)	0.143	0.074	0.196	0.149
General psychopathology	0.420⁎ (M: 0.490; W: 0.208)	0.142	0.222	0.652⁎⁎⁎ (M: 0.582⁎; W: 0.761⁎)	0.109	0.093	0.135	0.084
PANSS total	0.466⁎ (M: 0.509⁎;W: 0.378)	0.176	0.266	0.689⁎⁎⁎ (M: 0.583⁎; W:0.845⁎)	0.085	0.035	0.110	0.101
Residual change
Positive symptoms	0.134	− 0.032	0.020	0.326 (M: 0.228; W: 0.467)	− 0.057	− 0.040	− 0.142	− 0.006
Negative symptoms	0.174	− 0.067	− 0.034	0.506⁎ (M: 0.085; W: 0.912⁎⁎)	0.059	0.004	0.193	0.019
General psychopathology	0.222	− 0.018	0.050	0.491⁎ (M: 0.359; W: 0.714)	− 0.006	− 0.008	0.074	− 0.054
PANSS total	0.301	0.033	0.104	0.581⁎⁎ (M: 0.414; W: 0.827⁎)	0.030	0.002	0.084	0.018

M = men; W = women.

^#p = 0.06.

^⁎p < 0.05.

^⁎⁎p < 0.01.

^⁎⁎⁎p < 0.001.